Filing search / Inhibrx Biosciences, Inc. / "Fraud"

DEFM14A

INBX Inhibrx Biosciences, Inc.

26 Apr 24

Proxy related to merger

4:06pm

in the Merger Agreement will release a party from liability for fraud or intentional or willful breach of any of its representations, warranties, covenants … financial information and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s

DEFA14A

45583lx k1l2ilj4

23 Jan 24

Additional proxy soliciting materials

6:38am

8-K

EX-2.1

s6beopu

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.2

7ecyii pj15

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

D

gpshe3txg7

31 Aug 23

$200.00 mm in equity / options / securities to be acquired, sold $200.00 mm, 5 investors

4:06pm

8-K

EX-10.1

2yoc7l6zhezvhaff

29 Aug 23

Inhibrx Announces $200 Million Private Placement Financing

9:03am